Forte Biosciences, Inc. (FBRX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol FBRX
- Company Forte Biosciences, Inc.
- Price $6.05
- Changes Percentage -12.06
- Change -0.83
- Day Low $4.91
- Day High $7.18
- Year High $28.68
- Year Low $4.11
- Market Cap $39,819,104
- Price Avg 50 EMA (D) $7.62
- Price Avg 200 EMA (D) $10.87
- Exchange NASDAQ
- Volume 55,692
- Average Volume 35,295
- Open $7.18
- Previous Close $6.88
- EPS -12.17
- PE -0.50
- Earnings Announcement 2025-05-12 10:59:00
- Shares Outstanding $6,581,670
Company brief: FORTE BIOSCIENCES, INC. (FBRX )
- Healthcare
- Biotechnology
- Dr. Paul A. Wagner Ph.D.
- https://www.fortebiorx.com
- US
- N/A
- 04-13-2017
- US34962G1094
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.